The effects of oral (30 mg) and chewable (10 mg) isosorbide dinitrate on haemodynamics, venous capacitance, and calf blood flow were compared in a double-blind trial in 18 patients with refractory chronic congestive heart failure with pulmonary artery end-diastolic pressures >18 mmHg. Cardiac output and right heart pressures were measured with a Swan-Ganz thermodilution catheter, arterial pressure through an indwelling radial artery cannula, and venous capacitance and calf blood flow by vascular occlusion plethysmography. Both agents reduced pulmonary artery end-diastolic pressures > 10 per cent in 15 patients ('responders') but by .10 per cent in 3 others ('non-responders'). In the responders, both agents produced significant decreases in mean arterial pressure, in pulmonary artery end-diastolic pressures, and in mean right atrial pressure. Oral (but not chewable) isosorbide dinitrate produced a significant increase in cardiac index and stroke volume index while decreasing systemic vascular resistance and heart rate. Both agents increased venous capacitance significantly but without a comparable effect on calf blood flow. The onset of action for both agents was apparent within 10 minutes; the peak effect, however, occurred significantly earlier for the chewable isosorbide dinitrate, whereas the duration of action was longer for oral isosorbide dinitrate. The overall data thus indicate that both oral and chewable isosorbide dinitrate may have significant effects on vascular capacitance bed but because of its more pronounced effect on ventricular function and its more prolonged duration of action, oral isosorbide dinitrate appears to be the preferred agent for protracted oral treatment in congestive cardiac failure.
The effects of peripheral vasodilators upon cardiac haemodynamics have been studied extensively since the recognition of their efficacy in patients with heart failure secondary to acute myocardial infarction in the early 1970's (Majid et al., 1971; Franciosa et al., 1972; Gold et al., 1972; Chatterjee et al., 1973; Cohn, 1973) . After the initial documentation of the profound haemodynamic effects of intravenous vasodilators, attention has focused recently on the use of oral and sublingual preparations (Franciosa et al., 1974; Gray et al., 1975; Mikulic et al., 1975; Chatterjee et al., 1976; Kovick et al., 'Supported in part by SCOR Grant, National Institutes of Health, Bethesda, Maryland, USA. Received for publication 3 April 1978 3 April 1976 Mantle et al., 1976; Williams et al., 1977) as potential agents for the long-term management of cardiac failure, particularly in patients having satisfactory responses to intravenous agents in acute studies. Most prominent of this class of agents are hydralazine (Chatterjee et al., 1976) and nitrates (Franciosa et al., 1974; Gray et al., 1975; Mikulic et al., 1975; Kovick et al., 1976; Mantle et al., 1976; Williams et al., 1977) . Though both these regirnens have been found to improve symptoms as well as cardiac haemodynamics (Franciosa et a!., 1974; Gray et al., 1975; Mikulic et al., 1975;  Williams et a!., 1977) (Ganz and Swan, 1972) .
In 12 patients, venous capacitance (VC) and calf blood flow (CBF) were measured. Venous capacitance was measured in one of the lower extremities by the equilibrium method using a pneumatic plethysmograph (Vyden et al., 1974) 
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Oral isosorbide dinitrate Control 0 85-3 ± 3-4 88-3 ± 3-1 57-1 ± 4 8/29-5 ± 2-5 13-4 ± 2-1 Mean ± SEM Peak 69 ± 14-6 80-1 ± 3-6 § 78-2 ± 2-3* 41-3 + 4-8/*19-1 + 2-1* 8-8 + 1-7' Final 212 ± 9 9
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50-1 ± 4-4/ ¶124-3 ± 1-9* 10-7 + 1-7' *P < 0-001; tP < 0-005; TP < -011; SP < 0-02; ¶ < 0 05. (Franciosa et al., 1974; Mikulic et al., 1975) . Statistical analyses were carried out by the use of Student's t tests for paired and unpaired data.
Results
Patients in whom pulmonary artery diastolic pressure had decreased by more than 10 per cent relative to their control values were designated as responders, whereas those who failed to respond to oral isosorbide dinitrate (3 patients) and/or to chewable isosorbide dinitrate (3 patients) were designated as non-responders.
RESPONDERS: TIME OF ONSET, PEAK EFFECT, AND DURATION OF ACTION
There were no significant differences between the two sets of control values though the baseline cardiac index and systemic vascular resistance for the oral isosorbide dinitrate were somewhat lower and higher, respectively, than those for the chewable isosorbide dinitrate (Table) . The onset of action of the haemodynamic changes was usually apparent during the first 15 minutes for both drugs, the effects with chewable isosorbide dinitrate being noticeable earlier than those after oral isosorbide dinitrate which frequently occurred within the first 7 minutes of drug ingestion.
The differences between the effects of oral and chewable isosorbide dinitrate with respect to measured and derived haemodynamic variables are presented in the Table and Fig. 1-3 . The peak haemodynamic effects occurred significantly earlier with chewable isosorbide dinitrate (27 vs. 69 min, P < 0-01). Compared with the control values, the peak changes were statistically significant and of comparable magnitude for both oral and chewable isosorbide dinitrate with respect to intra-arterial pressure: 11-4 per cent vs. 9 3 per cent (Fig. 1) (Fig. 2) ; pulmonary vascular resistance: 37-8 per cent vs. 33 5 per cent, respectively. Both agents also increased stroke work index. However, only the oral isosorbide dinitrate produced a significant increase in cardiac index (14-8%) and stroke index (19-6%; Fig. 3 ), more significant improvement in left ventricular function (Fig. 4) . Only isosorbide dinitrate also produced a decrease in systemic vascular resistance (15-2%) and heart rate (6-1%) (Fig. 1) . Venous capacitance was significantly increased by both agents, the changes tending to be rnore pronounced with oral isosorbide dinitrate (75% vs. 29%; Fig. 3 Fig. 5 , patients who had the lowest initial venous capacitance had a tendency to exhibit the smallest change in both venous capacitance and pulmonary artery diastolic pressure after isosorbide dinitrate.
Discussion
The data from our double-blind comparative haemodynamic studies with oral and chewable isosorbide dinitrate in the same patients have indicated that both agents can produce sustained .and comparable reductions in the pulmonary capillary wedge pressure, the main determinant of puilmonary congestion; these findings agree with previous observations (Franciosa et al., 1974; Mikulic et al., 1975; Bussmann et al., 1977; Williams et al., 1977) . However, in the present study an important difference in the effects between oral and chewable isosorbide was found with respect to changes in stroke volume index and systemic vascular resistance. Administration of oral isosorbide resulted in a 20 per cent increase in stroke volume index and a 15 per cent decrease in systemic vascular resistance whereas the effect of chewable isosorbide was negligible. Williams et al. (1977) who noted a consistent decrease in left ventricular filling pressure using oral isosorbide failed to document significant increases in stroke volume index or decreases in systemic vascular resistance, except in patients whose pulmonary capillary pressure had not fallen to levels below 12 nmmHg after drug administration. Even though the oral dose used in the present study was larger than that (20 mg) given by Williams and his colleagues, the effect on the left ventricular filling pressure was comparable. The differences between the two sets of data suggest that the type of response observed may be dose-dependent, and that a larger dose of oral isosorbide dinitrate may induce a more con- group.bmj.com on June 25, 2017 -Published by http://heart.bmj.com/ Downloaded from sistent afterload reduction and consequent functional improvement. Franciosa et al. (1974) also reported a decrease in left ventricular filling pressure after oral isosorbide dinitrate, though the observed change in their study was smaller than that in ours (25% vs. 35%). Systemic vascular resistance and other flow-dependent variables were not measured in their study. Bussmann et al. (1977) , treating patients with left ventricular failure secondary to an acute myocardial infarction, found a similar fall in left ventricular filling pressure using the same total dose of oral isosorbide dinitrate (30 mg), though it was administered in two doses (10 and 20 mg) at 30-minute intervals. The major haemodynamic changes were apparent after the initial dose (10 mg). In their study the criterion for left ventricular failure was a left ventricular filling pressure greater than 20 mmHg, and it was only among this group that a fall in left ventricular filling pressure was associated with an increase in cardiac output.
A significant decrease in heart rate after oral but not chewable isosorbide dinitrate, observed in our study as well as in those of others in patients with congestive heart failure using nitroprusside (Franciosa et al., 1972) or glyceryl trinitrate (Gold et al., 1972) , is of particular interest. The decline in heart rate which occurred despite a fall in blood pressure has not been a consistent finding, however, in patients without heart failure (Kasparian et al., 1975; Bussmann et al., 1977) .
In the only previous study on the haemodynamic effects of chewable isosorbide dinitrate in patients with congestive heart failure which did not include flow-related measurements, Mikulic et al. (1975) found a similar fall in left ventricular filling pressure but they did not find a significant change in arterial pressure. This difference was probably reJated to the much lower resting blood pressure in their patient population (106/78 vs. 133/66).
The differences in the response in stroke index and systemic vascular resistance induced by the two agents further illustrate the difficulties inherent in the interpretation of data from comparative drug studies in man. Usually such studies are conducted using drugs of differing chemical structures, and dissimilar responses are often attributed to differences in the intrinsic pharmacological properties of the agents themselves. Our study shows that substantial differences in response may be obtained in the same patient with the same drug at approximately comparable doses, when the mode of administration is altered. Whether this difference is in fact related to the route of drug administration cannot, however, be ascertained from the results of the present study.
In addition to the differences in the effects on stroke volume and systemic vascular resistance, the two agents were found to-be substantially different in the peak effect and overall duration of action. The onset of action of chewable isosorbide was invariably apparent within 10 minutes of drug administration with a peak activity being attained by 27 minutes, thus making it a very suitable compound for acute administration in patients in hospital. Since its mean duration of action is only 136 minutes, which is very similar to that reported for sublingual isosorbide dinitrate (Gray et al., 1975; Kovick et al., 1976) , it is obviously of limited value for longterm treatment of congestive cardiac failure. In contrast, oral isosorbide had a similar onset of action, starting within 15 to 20 minutes but reaching peak activity in 69 minutes with its effect being sustained for at least 3i hours; these characteristics of the drug, as have also been noted by previous investigators (Franciosa et al., 1974; Williams et al., 1977) , greatly enhance clinical usefulness for long-term treatment.
Our measurements of peripheral vascular functions undertaken in association with the haemodynamic studies in 12 of the 18 patients suggest that both agents might exert their major effect by peripheral venodilatations. In 6 of 9 responders to oral isosorbide dinitrate and in 6 ofthe 10 responders to chewable isosorbide dinitrate, venous capacitance was near normal before drug administration; it increased significantly after both oral and chewable isosorbide dinitrate The mean increases in venous capacitance tended to parallel the decreases in left ventricular filling pressure. In contrast, venous capacitance was abnormally low in all the patients who exhibited little or no response to drug administration. The arterial flow to the lower limbs showed little change in both responders as well as nonresponders to the drugs. It is of course possible that additional specific vascular beds may also be particularly responsive to the vasodilator action of isosorbide. The dramatic fall in pulmonary vascular resistance and the fall in pulmonary artery systolic pressure, often occurring even in the absence of changes in left ventricular filling pressure, may suggest a direct vasodilator effect of the nitrate on the pulmonary vasculature as has been found with glyceryl trinitrate (Ferrer et al., 1966) . Furthermore, the increase in cardiac index and stroke index induced by oral isosorbide, despite a consistent decline in arterial pressure, is suggestive of a concomitant element of afterload reduction (Cohn, 1973) . Although limited, these data suggest that the failure of chewable as well as oral isosorbide to induce the expected response in the presence of severe heart failure in certain patients may be 
